Report on orphan drugs in Europe suggests changing pharma incentives
“The regulations have not adequately managed to support development in areas where the need for medicines is greatest,” a European Commission report finds.
“The regulations have not adequately managed to support development in areas where the need for medicines is greatest,” a European Commission report finds.
The dominance of group purchasing organizations (GPOs) is often cited as a cause of generic drug shortages. The problem is more complicated than that.
New research from academic hospitals reveals significant limitations of large language models (LLMs) in medical settings.
Why a British hospital, and not a drugmaker, is trying to get a rare disease therapy approved.
“Colombia is planting a flag for global health equity,” said Peter Maybarduk, who heads the access to medicines campaign at Public Citizen.
Takeda Pharmaceuticals has left BIO, the fourth departure of a major member since December, the company confirmed.
The FTC’s ban on noncompete agreements, approved Tuesday, was immediately challenged in a lawsuit filed in the Eastern District of Texas.
Costs for the U.S. health care system and the federal government will climb thanks to weight loss drugs, two new reports show.
The Supreme Court seemed divided over the Biden administration’s argument that an Idaho abortion ban conflicts with federal law.
Genetic evidence of the H5N1 bird flu virus was found in grocery store milk in the United States this week, according to the Food and…
H5N1 bird flu updates: Stories on this page include the risk of avian flu transmission to humans, what would be needed for wide availability of…